Chloroprocaine 2% vs Ropivacaine 0.75% in Ultrasound-guided Axillary Nerve Block
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The Study evaluate the non-inferiority of Test product (Chloroprocaine 2%) versus Reference
product (Ropivacaine 0.75%) in terms of proportion of subjects with a successful block for
distal upper limb surgeries Successful block: anaesthesia adequate for the surgery without
any supplementation in the first 45 min.